MotivaImplants® MotivaImagine® Careers

Investors

Press Releases

Press Releases

September 16, 2019
Establishment Labs Receives Notice of Allowance for Key U.S. Patent Application Covering Company’s Implant Surface Technology and Announces 510(k) Submission for its Tissue Expander
NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that the Company has received a Notice of Allowance from the U.S.
Read More
August 28, 2019
Establishment Labs to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
NEW YORK , Aug. 28, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will participate in a
Read More
August 13, 2019
Establishment Labs Reports Second Quarter 2019 Financial Results
NEW YORK , Aug. 13, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the second quarter ended June 30, 2019 .
Read More
July 30, 2019
Establishment Labs to Announce Second Quarter 2019 Financial Results on August 13, 2019
NEW YORK , July 30, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the second quarter
Read More
June 17, 2019
Establishment Labs Announces Additional Financing and Improved Terms with Amendment to Existing Credit Agreement
NEW YORK, June 17, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has entered into an amendment to its existing credit agreement (the
Read More
June 6, 2019
Establishment Labs Announces Appointment of Lisa Gersh to Board of Directors
NEW YORK, June 06, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the appointment of Lisa Gersh to its Board of Directors, effective
Read More
May 22, 2019
Establishment Labs Holdings Inc. and Allergan Sales, LLC Extend Distribution and Supply Agreement for MotivaImagine® Insertion Sleeve
NEW YORK, May 22, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has reached an agreement with Allergan Sales, LLC to extend an
Read More
May 20, 2019
Establishment Labs to Present at Jefferies 2019 Healthcare Conference
NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that Chief Executive Officer Juan José Chacón-Quirós will be presenting
Read More
May 15, 2019
Establishment Labs Reports First Quarter 2019 Financial Results
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the first quarter ended March 31, 2019.
Read More
April 26, 2019
Establishment Labs to Present at UBS Global Healthcare Conference
NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will be presenting at the
Read More
Displaying 1 - 10 of 14